Skip to main content

Table 1 Demographics, clinical characteristics and neuropsychological assessment of the study sample

From: The protective impact of education on brain structure and function in Alzheimer’s disease

Characteristics

AD

(n = 57)

aMCI

(n = 57)

HC

(n = 48)

p Value

Women (%)

31 (54)

35 (61)

30(63)

0.645b

Age (years)

67.74 (8.28)

66.33 (7.47)

66.75 (7.41)

0.613a

Years of education

6.14 (5.38)

9.53 (4.71)

11.69(3.48)

<0.001a

MMSE score

15.28 (5.22)

26.35 (1.58)

28.60(1.11)

<0.001a

Clinical Dementia Rating Scale

 1 (%)

21 (37)

   

 2 (%)

22 (39)

   

 3 (%)

14 (25)

   

 TIV (cm3)

1314.27 (109.09)

1352.93

(99.70)

1368.67

(103.03)

0.023a

 Frame-wise displacement (mm)

0.21(0.14)

0.22(0.16)

0.18(0.11)

0.466a

 Fazekas score

2(1–3)

1(0.5–2.5)

1(1–2)

0.229c

neuropsychological tests

 AVLT (immediate)

2.01(1.62)

5.89(2)

9.04(1.76)

<0.001a

 AVLT (delay)

0(0–0)

4.46(3.08)

10.13(2.77)

<0.001c

 AVLT (recognize)

10(6–12)

12(11–14)

14(13.5–15)

<0.001c

VFT (Animals)

9(7–10)

13(10.5–14.5)

18.13(3.93)

<0.001c

DSpF

5(4–6)

7(6–8)

8(7–8)

<0.001c

DSpB

3(2–3)

4(3–5)

5(4–6)

<0.001c

cognitive functionscore

 Episodic memoryd

−2.70(1.65)

0.27(1.58)

2.88(1.22)

<0.001a

 Semantic memoryd

−0.85(0.63)

0.04(− 0.43–0.32)

1.0(0.74)

<0.001c

 Working memoryd

−1.48(1.63)

0.29(1.24)

1.42(1.32)

<0.001a

  1. Datas with normal distribution are expressed as mean (SD) or as percentage
  2. Datas with non-normal distribution are expressed as median (interquartile range)
  3. aGroup difference was tested by using one-way analysis of variance (ANOVA)
  4. bGroup difference was tested by using Pearson’s Chi-square test
  5. cGroup difference was tested by using Kruskal-Wallis test
  6. dEach cognitive composite score was computed by converting raw scores on each component of neuropsychological tests to z scores, using the mean and SD for all participants in the study, and averaging the z scores to yield the composite score
  7. Abbreviations: AD Alzheimer’s disease; aMCI amnestic mild cognitive impairment;, healthy control; MMSE Mini-Mental State Examination; TIV total intracranial volume; SD standard deviations; AVLT auditory verbal learning test; VFT verbal fluency test; DSpF Digit Span Forward; DSpB Digit Span Backward